Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
Okuma HS, Watanabe K, Tsuchihashi K, Machida R, Sadachi R, Hirakawa A, Ariyama H, Kanai M, Kamikura M, Anjo K, Hiramitsu A, Sekine S, Okita N, Mano H, Nishikawa H, Nakamura K, Yonemori K. Okuma HS, et al. Among authors: watanabe k. Clin Cancer Res. 2023 Dec 15;29(24):5079-5086. doi: 10.1158/1078-0432.CCR-23-1807. Clin Cancer Res. 2023. PMID: 37819940 Free PMC article. Clinical Trial.
The cancer epigenome: Non-cell autonomous player in tumor immunity.
Kato S, Maeda Y, Sugiyama D, Watanabe K, Nishikawa H, Hinohara K. Kato S, et al. Among authors: watanabe k. Cancer Sci. 2023 Mar;114(3):730-740. doi: 10.1111/cas.15681. Epub 2022 Dec 18. Cancer Sci. 2023. PMID: 36468774 Free PMC article. Review.
A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.
Shibuya K, Misawa S, Kimura H, Noto Y, Sato Y, Sekiguchi Y, Iwai Y, Mitsuma S, Beppu M, Watanabe K, Fujimaki Y, Tsuji Y, Shimizu T, Mizuno T, Nakagawa M, Sawaguchi K, Hanaoka H, Kuwabara S. Shibuya K, et al. Among authors: watanabe k. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):353-8. doi: 10.3109/21678421.2015.1038277. Epub 2015 May 11. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 25960085 Clinical Trial.
Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, Nomura F, Shibuya K, Sekiguchi Y, Iwai Y, Watanabe K, Amino H, Ohwada C, Takeuchi M, Sakaida E, Nakaseko C, Kuwabara S. Misawa S, et al. Among authors: watanabe k. BMJ Open. 2015 Nov 11;5(11):e009157. doi: 10.1136/bmjopen-2015-009157. BMJ Open. 2015. PMID: 26560063 Free PMC article.
Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.
Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y. Takamatsu K, et al. Among authors: watanabe k. Ann Clin Transl Neurol. 2018 Sep 23;5(11):1421-1427. doi: 10.1002/acn3.654. eCollection 2018 Nov. Ann Clin Transl Neurol. 2018. PMID: 30480036 Free PMC article.
Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain.
Watanabe K, Hirano S, Kojima K, Nagashima K, Mukai H, Sato T, Takemoto M, Matsumoto K, Iimori T, Isose S, Omori S, Shibuya K, Sekiguchi Y, Beppu M, Amino H, Suichi T, Yokote K, Uno T, Kuwabara S, Misawa S. Watanabe K, et al. J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1082-1087. doi: 10.1136/jnnp-2017-316601. Epub 2018 Apr 7. J Neurol Neurosurg Psychiatry. 2018. PMID: 29627772
Altered axonal excitability properties and nerve edema in POEMS syndrome.
Mitsuma S, Misawa S, Shibuya K, Isose S, Sekiguchi Y, Iwai Y, Beppu M, Watanabe K, Amino H, Kuwabara S. Mitsuma S, et al. Among authors: watanabe k. Clin Neurophysiol. 2015 Oct;126(10):2014-8. doi: 10.1016/j.clinph.2015.01.018. Epub 2015 Feb 11. Clin Neurophysiol. 2015. PMID: 25735476
15,988 results
You have reached the last available page of results. Please see the User Guide for more information.